CrosswordNewsletters
DAILY BEAST
ALL
  • Cheat Sheet
  • Politics
  • Crime
  • Entertainment
  • Media
  • Innovation
  • Covid-19
  • World
  • U.S. News
  • Scouted
  • Travel
CHEAT SHEET
    POLITICS
    • Biden World
    • Elections
    • Opinion
    • National Security
    • Congress
    • Pay Dirt
    • The New Abnormal
    • Right Richter
    • Trumpland
    MEDIA
    • Daytime Talk
    • Late-Night
    • Fox News
    U.S. NEWS
    • Identities
    • Crime
    • Race
    • LGBT
    • Extremism
    • Coronavirus
    WORLD
    • Russia
    • Europe
    • China
    • Middle East
    SCIENCE
    • Hunt for the Cure
    • Rabbit Hole
    TRAVEL
      ENTERTAINMENT
      • TV
      • Movies
      • Music
      • Comedy
      • Sports
      • Sex
      • TDBs Obsessed
      • Awards Shows
      • The Last Laugh
      HALF-FULL
        CULTURE
        • Power Trip
        • Fashion
        • Books
        • Royalist
        TECH
        • Disinformation
        SCOUTED
        • Face Masks
        • Clothing
        • Technology
        • Bedroom
        • Kitchen
        • Home
        • Fitness
        • The Case For
        • I'm Looking For
        • New Kids On the Block
        COUPONS
        • Adidas Promo Codes
        • DoorDash Promo Codes
        • H&M Coupons
        • Hotwire Promo Codes
        • Wine.com Discounts
        • Vitacost Coupons
        • Spanx Promo Codes
        • StubHub Promo Codes
        Products
        NewslettersPodcastsCrosswordsSubscription
        FOLLOW US
        GOT A TIP?

        SEARCH

        HOMEPAGE
        Rabbit Hole

        Could This Drug Stop COVID’s Sabotage of Your Immune System?

        POTENTIAL LIFESAVER

        One way the coronavirus may kill people is by provoking an overreaction by the immune system. Maybe, just maybe, the arthritis drug tocilizumab can calm the immune-response storm.

        David Axe

        Updated Apr. 28, 2020 4:42PM ET / Published Apr. 28, 2020 4:43AM ET 

        Photo Illustration by The Daily Beast/Getty

        A South San Francisco biotech company is trying to determine whether an arthritis drug could help treat COVID-19. It’s way too soon to say for sure, but there are signs the firm might be onto something.

        Extra emphasis on might. There’s still a lot we don’t know about SARS-CoV-2 and the disease it causes. We know even less about effective treatments.

        On March 23, Genentech got the Food and Drug Administration’s approval to begin testing the drug tocilizumab on COVID-19 patients. The company said it administered its first treatments on April 3. In all, Genentech plans to treat 330 patients at 55 clinics all over the world, including 15 in the United States.

        READ THIS LIST

        DAILY BEAST
        • Podcasts
        • Cheat Sheet
        • Politics
        • Crime
        • Entertainment
        • Media
        • Covid-19
        • Half Full
        • U.S. News
        • Scouted
        • Travel
        • Subscription
        • Crossword
        • Newsletters
        • Podcasts
        • About
        • Contact
        • Tips
        • Jobs
        • Advertise
        • Help
        • Privacy
        • Code of Ethics & Standards
        • Diversity
        • Terms & Conditions
        • Copyright & Trademark
        • Sitemap
        • Coupons
        © 2022 The Daily Beast Company LLC